Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  6. Financials
    300760   CNE100003G67

SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

(300760)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 132 778221 134517 884528 826--
Entreprise Value (EV)1 132 778206 861502 020508 252502 148498 986
P/E ratio 32,7x47,2x77,8x64,7x53,0x43,2x
Yield 0,92%0,82%0,59%0,54%0,66%0,79%
Capitalization / Revenue 9,65x13,4x24,6x20,5x16,9x14,0x
EV / Revenue 9,65x12,5x23,9x19,7x16,1x13,2x
EV / EBITDA 28,8x35,8x63,3x53,9x43,7x35,6x
Price to Book 8,76x11,9x22,2x17,7x13,9x11,1x
Nbr of stocks (in thousands) 1 215 6911 215 6911 215 6911 215 691--
Reference price (CNY) 109182426435435435
Announcement Date 02/27/201902/27/202004/28/2021---
1 CNY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 13 75316 55621 02625 75931 23137 867
EBITDA1 4 6165 7847 9309 43711 49814 004
Operating profit (EBIT)1 4 2785 3797 4559 11211 13913 634
Operating Margin 31,1%32,5%35,5%35,4%35,7%36,0%
Pre-Tax Profit (EBT)1 4 2385 3687 4389 36911 41114 103
Net income1 3 7194 6816 6588 17710 00312 356
Net margin 27,0%28,3%31,7%31,7%32,0%32,6%
EPS2 3,343,855,486,728,2110,1
Dividend per Share2 1,001,502,502,352,863,45
Announcement Date 02/27/201902/27/202004/28/2021---
1 CNY in Million
2 CNY
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q1 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4
Net sales1 4 7414 9625 7816 4867 2776 171
EBITDA1 ---2 0612 6592 278
Operating profit (EBIT)1 1 4711 4511 9052 2272 4142 056
Operating Margin 31,0%29,2%33,0%34,3%33,2%33,3%
Pre-Tax Profit (EBT)1 1 4811 4211 9032 1592 8172 510
Net income1 1 3131 2951 7151 9332 5212 235
Net margin 27,7%26,1%29,7%29,8%34,6%36,2%
EPS2 1,081,061,411,841,901,56
Dividend per Share ------
Announcement Date 04/28/202004/28/202104/28/2021---
1 CNY in Million
2 CNY
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 -14 27315 86520 57426 67829 840
Leverage (Debt / EBITDA) --2,47x-2,00x-2,18x-2,32x-2,13x
Free Cash Flow1 -3 9497 6907 2689 39911 534
ROE (Net Profit / Equities) 42,2%27,9%32,3%29,1%28,3%28,1%
Shareholders' equity1 8 82216 77120 61828 09235 40644 024
ROA (Net Profit / Asset) 20,6%19,8%22,6%22,0%22,0%23,5%
Assets1 18 03323 62529 47037 15845 54952 487
Book Value Per Share2 12,515,319,124,531,339,2
Cash Flow per Share2 3,323,887,306,477,7910,0
Capex1 6757731 1801 0461 2281 285
Capex / Sales 4,91%4,67%5,61%4,06%3,93%3,39%
Announcement Date 02/27/201902/27/202004/28/2021---
1 CNY in Million
2 CNY
Key data
Capitalization (CNY) 528 825 700 710
Capitalization (USD) 81 591 276 686
Net sales (CNY) 21 025 846 390
Net sales (USD) 3 244 330 150
Number of employees 11 833
Sales / Employee (CNY) 1 776 882
Sales / Employee (USD) 274 176
Free-Float 100%
Free-Float capitalization (CNY) 528 825 700 710
Free-Float capitalization (USD) 81 591 276 686
Avg. Exchange 20 sessions (CNY) 1 885 972 515
Avg. Exchange 20 sessions (USD) 291 009 331
Average Daily Capital Traded 0,36%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA